Recent research focusing on Retatrutide at a dosage of 30mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may amplify the drug's ability to regulate blood glucose, potentially offering more significant outcomes for individuals with insulin resistance. Further investigation is underway to fully